These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 18461629)

  • 1. Efficient neutralizing activity of cocktailed recombinant human antibodies against hepatitis A virus infection in vitro and in vivo.
    Cao J; Meng S; Li C; Ji Y; Meng Q; Zhang Q; Liu F; Li J; Bi S; Li D; Liang M
    J Med Virol; 2008 Jul; 80(7):1171-80. PubMed ID: 18461629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Baculovirus expression of two human recombinant neutralizing IgG monoclonal antibodies to hepatitis A virus].
    Cao JY; Liang MF; Meng QL; Wang XF; Xu YG; Guo KQ; Zhan MY; Bi SL; Li DX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Mar; 18(1):20-3. PubMed ID: 15340519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing human monoclonal antibodies to hepatitis A virus recovered by phage display.
    Kim SJ; Jang MH; Stapleton JT; Yoon SO; Kim KS; Jeon ES; Hong HJ
    Virology; 2004 Jan; 318(2):598-607. PubMed ID: 14972527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Fab antibodies derived from phage display library neutralize hepatitis A virus in vitro.
    Cao J; Liang M; Guo K
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Dec; 14(4):313-6. PubMed ID: 11471014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of anti-idiotypic antibodies mimicking antibody- and receptor-binding sites on hepatitis A virus.
    Kiyohara T; Totsuka A; Yoneyama T; Ishii K; Ito T; Wakita T
    Arch Virol; 2009; 154(8):1263-9. PubMed ID: 19578927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four chimpanzee monoclonal antibodies isolated by phage display neutralize hepatitis a virus.
    Schofield DJ; Satterfield W; Emerson SU; Purcell RH
    Virology; 2002 Jan; 292(1):127-36. PubMed ID: 11878915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of recombinant human anti-HAV monoclonal antibody.
    Wei JS; Tao R; Sun WW; Jia Q; Li C; Liang MF
    Sheng Wu Gong Cheng Xue Bao; 2004 Mar; 20(2):257-61. PubMed ID: 15969118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunogenicity of experimentally combined hepatitis A and hepatitis E vaccine at different dosage ratio].
    Dong C; Dai X; Meng JH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb; 23(2):130-3. PubMed ID: 17286906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of hepatitis A virus mimotopes by phage display, antigenicity and immunogenicity.
    Larralde OG; Martinez R; Camacho F; Amin N; Aguilar A; Talavera A; Stott DI; Perez EM
    J Virol Methods; 2007 Mar; 140(1-2):49-58. PubMed ID: 17129616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
    Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
    J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should one vaccinate patients with chronic liver disease for hepatitis A virus in India?
    Anand AC; Nagpal AK; Seth AK; Dhot PS
    J Assoc Physicians India; 2004 Oct; 52():785-7. PubMed ID: 15909855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic relevance of immunoglobulin G avidity for hepatitis A virus.
    Roque-Afonso AM; Grangeot-Keros L; Roquebert B; Desbois D; Poveda JD; Mackiewicz V; Dussaix E
    J Clin Microbiol; 2004 Nov; 42(11):5121-4. PubMed ID: 15528704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first experimental study on a candidate combined vaccine against hepatitis A and hepatitis E.
    Dong C; Dai X; Meng JH
    Vaccine; 2007 Feb; 25(9):1662-8. PubMed ID: 17156900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope-based recombinant diagnostic antigen to distinguish natural infection from vaccination with hepatitis A virus vaccines.
    Su Q; Guo M; Jia Z; Qiu F; Lu X; Gao Y; Meng Q; Tian R; Bi S; Yi Y
    J Virol Methods; 2016 Jul; 233():41-5. PubMed ID: 26994964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
    Ahmed M; Munshi SU; Nessa A; Ullah MS; Tabassum S; Islam MN
    Indian J Med Microbiol; 2009; 27(1):48-50. PubMed ID: 19172060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis A virus antibodies in immunoglobulin preparations.
    Farcet MR; Planitzer CB; Stein O; Modrof J; Kreil TR
    J Allergy Clin Immunol; 2010 Jan; 125(1):198-202. PubMed ID: 19962745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental hepatitis A virus (HAV) infection in Callithrix jacchus: early detection of HAV antigen and viral fate.
    Pinto MA; Marchevsky RS; Baptista ML; de Lima MA; Pelajo-Machado M; Vitral CL; Kubelka CF; Pissurno JW; Franca MS; Schatzmayr HG; Gaspar AM
    Exp Toxicol Pathol; 2002 Feb; 53(6):413-20. PubMed ID: 11930901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on vaccination schedule of inactivated hepatitis A vaccine].
    Hu Y; Tan S; Jin W
    Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):618-20. PubMed ID: 11798830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid detection of anti-hepatitis A virus neutralizing antibodies in a microplate enzyme immunoassay.
    Azizi A; Sirskyj D; Weltzin R; Anderson DE; Diaz-Mitoma F
    J Med Microbiol; 2009 Nov; 58(Pt 11):1433-1436. PubMed ID: 19608692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applied biotechnology for production of immunoglobulin Y specific to hepatitis A virus.
    de Paula VS; da Silva Ados S; de Vasconcelos GA; Iff ET; Silva ME; Kappel LA; Cruz PB; Pinto MA
    J Virol Methods; 2011 Jan; 171(1):102-6. PubMed ID: 20971134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.